AAM Launches Further Broadside At Proposed Blocking Act

Proposed Act ‘Well-Intended But Misguided,’ AAM Claims

 
• By Dean Rudge
  
Delays
Weakening the 180-day exclusivity incentive will delay patient access, the AAM insists • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Policy & Regulation

More from Generics Bulletin